Literature DB >> 17556593

Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury.

Stefan Frantz1, Jochen Tillmanns, Peter J Kuhlencordt, Isabel Schmidt, Anna Adamek, Charlotte Dienesch, Thomas Thum, Steve Gerondakis, Georg Ertl, Johann Bauersachs.   

Abstract

Nuclear factor kappaB (NF-kappaB) is a ubiquitous transcription factor activated by various stimuli implicated in ischemia-reperfusion injury. However, the role of NF-kappaB in cardiac ischemia-reperfusion injury has not yet been well defined. Therefore, we investigated reperfusion damage in mice with targeted deletion of the NF-kappaB subunit p50. Electrophoretic mobility shift assays validated NF-kappaB activation in wild-type (WT) but not p50 knockout (KO) mice. KO and WT animals underwent 30 minutes of coronary artery ligation and 24 hours of reperfusion in vivo. Ischemia-reperfusion damage was significantly reduced in the p50 KO when compared with matching WT mice. Although adhesion molecules such as intercellular adhesion molecule were up-regulated in left ventricles of p50 KO animals, fewer neutrophils infiltrated the infarct area, suggesting leukocytes as a potential mediator of the protection observed in the p50 KO. This was confirmed in adoptive transfer experiments: whereas transplantation of KO bone marrow in KO animals sustained the protective effect on ischemia-reperfusion injury, transplantation of WT bone marrow in KO animals abolished it. Thus, deletion of the NF-kappaB subunit p50 reduces ischemia-reperfusion injury in vivo, associated with less neutrophil infiltration. Bone marrow transplantation experiments indicate that impaired NF-kappaB activation in p50 KO leukocytes attenuates cardiac damage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17556593      PMCID: PMC1934536          DOI: 10.2353/ajpath.2007.061042

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

Review 1.  Activators and target genes of Rel/NF-kappaB transcription factors.

Authors:  H L Pahl
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

Review 2.  Regulation of secondary lymphoid organ development by the nuclear factor-kappaB signal transduction pathway.

Authors:  Falk Weih; Jorge Caamaño
Journal:  Immunol Rev       Date:  2003-10       Impact factor: 12.988

3.  Possible new role for NF-kappaB in the resolution of inflammation.

Authors:  T Lawrence; D W Gilroy; P R Colville-Nash; D A Willoughby
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

4.  Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes.

Authors:  S Frantz; R A Kelly; T Bourcier
Journal:  J Biol Chem       Date:  2000-11-16       Impact factor: 5.157

5.  Ischemia-reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine.

Authors:  B Chandrasekar; J B Smith; G L Freeman
Journal:  Circulation       Date:  2001-05-08       Impact factor: 29.690

6.  Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype.

Authors:  Edwin Kanters; Marion J J Gijbels; Ingeborg van der Made; Monique N Vergouwe; Peter Heeringa; Georg Kraal; Marten H Hofker; Menno P J de Winther
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

7.  Peroxisome proliferator activated-receptor agonism and left ventricular remodeling in mice with chronic myocardial infarction.

Authors:  Stefan Frantz; Kai Hu; Julian Widder; Barbara Bayer; Catharina Clara Witzel; Isabel Schmidt; Paolo Galuppo; Jörg Strotmann; Georg Ertl; Johann Bauersachs
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

8.  In vivo cardioprotection by N-acetylcysteine and isosorbide 5-mononitrate in a rat model of ischemia-reperfusion.

Authors:  Laura Calvillo; Serge Masson; Monica Salio; Loredana Pollicino; Noeleen De Angelis; Fabio Fiordaliso; Antonio Bai; Pietro Ghezzi; Francesco Santangelo; Roberto Latini
Journal:  Cardiovasc Drugs Ther       Date:  2003-05       Impact factor: 3.727

9.  Gene transfer of IkappaBalpha limits infarct size in a mouse model of myocardial ischemia-reperfusion injury.

Authors:  Francesco Squadrito; Barbara Deodato; Giovanni Squadrito; Paolo Seminara; Maria Passaniti; Francesco S Venuti; Mauro Giacca; Letteria Minutoli; Elena B Adamo; Maria Bellomo; Rolando Marini; Mariarosaria Galeano; Herbert Marini; Domenica Altavilla
Journal:  Lab Invest       Date:  2003-08       Impact factor: 5.662

10.  NFkappaB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes.

Authors:  J G Mabley; G Haskó; L Liaudet; F G Soriano; F Soriano; G J Southan; A L Salzman; C Szabó
Journal:  J Endocrinol       Date:  2002-06       Impact factor: 4.286

View more
  24 in total

1.  Reducing effect of IL-32α in the development of stroke through blocking of NF-κB, but enhancement of STAT3 pathways.

Authors:  Chul Ju Hwang; Hyung-Mun Yun; Yu Yeon Jung; Dong Hun Lee; Na Young Yoon; Hyun Ok Seo; Jin-Yi Han; Ki-Wan Oh; Dong Young Choi; Sang-Bae Han; Do Young Yoon; Jin Tae Hong
Journal:  Mol Neurobiol       Date:  2014-05-24       Impact factor: 5.590

2.  Exercise preconditioning attenuates pressure overload-induced pathological cardiac hypertrophy.

Authors:  Tongyi Xu; Hao Tang; Ben Zhang; Chengliang Cai; Xiaohong Liu; Qingqi Han; Liangjian Zou
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

3.  NF-κB and hypoxia: a double-edged sword in atherosclerosis.

Authors:  Xinghui Sun; Mark W Feinberg
Journal:  Am J Pathol       Date:  2012-09-20       Impact factor: 4.307

4.  Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion-induced Myocardial Injury and Adverse Remodeling.

Authors:  John M Erikson; Anthony J Valente; Srinivas Mummidi; Hemanth Kumar Kandikattu; Vincent G DeMarco; Shawn B Bender; William P Fay; Ulrich Siebenlist; Bysani Chandrasekar
Journal:  J Biol Chem       Date:  2017-01-04       Impact factor: 5.157

5.  Nuclear Factor (NF) kappaB polymorphism is associated with heart function in patients with heart failure.

Authors:  Diogo G B Santos; Marina F Resende; José G Mill; Alfredo J Mansur; José E Krieger; Alexandre C Pereira
Journal:  BMC Med Genet       Date:  2010-06-09       Impact factor: 2.103

Review 6.  The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.

Authors:  Sumanth D Prabhu; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

Review 7.  The multiple facets of toll-like receptors in transplantation biology.

Authors:  Maria-Luisa Alegre; Jaklien Leemans; Alain Le Moine; Sandrine Florquin; Virginie De Wilde; Anita Chong; Michel Goldman
Journal:  Transplantation       Date:  2008-07-15       Impact factor: 4.939

8.  Bioluminescence imaging visualizes activation of nuclear factor-kappaB in mouse cardiac transplantation.

Authors:  Lianli Ma; Zhidan Xiang; Taylor P Sherrill; Lei Wang; Timothy S Blackwell; Philip Williams; Anita Chong; Ravi Chari; Deng Ping Yin
Journal:  Transplantation       Date:  2008-03-27       Impact factor: 4.939

9.  Anti-inflammatory effect of protocatechuic aldehyde on myocardial ischemia/reperfusion injury in vivo and in vitro.

Authors:  Guo Wei; Yue Guan; Ying Yin; Jialin Duan; Dan Zhou; Yanrong Zhu; Wei Quan; Miaomiao Xi; Aidong Wen
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

Review 10.  Post-infarct remodelling: contribution of wound healing and inflammation.

Authors:  Stefan Frantz; Johann Bauersachs; Georg Ertl
Journal:  Cardiovasc Res       Date:  2008-10-31       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.